For investors wondering whether Hims & Hers Health still offers good value after its rise as a telehealth brand, or if the easier gains are already behind it, this article walks through what the current price could be implying about the business.

The stock last closed at US$31.69, with a 7 day return of an 8.7% decline, a 30 day return of a 14.8% decline, a year to date return of a 5.1% decline, a 1 year return of 22.4%, and a 3 year return that is a very large multiple of its earlier level, alongside a 5 year return of 75.7%.

Recent coverage around Hims & Hers Health has focused on its role in online healthcare and consumer telehealth services, which has kept investor attention on how scalable its model might be. This context…